Pentoxifylline 400 MG
Sponsors
University Health Network, Toronto, Asmaa Abdelfattah Elsayed, Al-Azhar University, Tanta University, Mostafa Bahaa
Conditions
Bipolar DepressionChronic Kidney DiseaseChronic Kidney DiseasesDiabetes Type 2Embryo TransferEpilepsyIVFInfertility
Early Phase 1
Phase 2
Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis
CompletedNCT05558761
Start: 2022-10-10End: 2024-04-20Updated: 2025-08-11
Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
RecruitingNCT05575505
Start: 2023-02-02End: 2026-02-28Target: 44Updated: 2025-03-04
Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy
RecruitingNCT05637086
Start: 2022-12-20End: 2027-11-20Target: 90Updated: 2024-07-18
Role of Pentoxifylline and Celecoxib in Parkinsonism
CompletedNCT05962957
Start: 2023-08-07End: 2024-09-20Updated: 2025-08-12
Phase 3
Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease
Active, not recruitingNCT05284656
Start: 2022-01-08End: 2026-12-19Updated: 2025-06-11
Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients
RecruitingNCT06421870
Start: 2024-03-01End: 2025-07-31Target: 210Updated: 2024-05-20
Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes
RecruitingNCT07499817
Start: 2023-10-01End: 2026-04-30Target: 100Updated: 2026-03-30